Skip to content

Bradycardia Recognition and Detection in Young Infants Part-I

Bradycardia Recognition and Detection in Young Infants Using the Owlet OSS 3.0 Monitor (Brady-I Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05774470
Acronym
BRADY-I
Enrollment
70
Registered
2023-03-17
Start date
2023-04-22
Completion date
2023-07-29
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia of Newborn, Neonatal Bradycardia

Brief summary

This prospective cohort study will determine the diagnostic accuracy of the Owlet OSS 3.0 monitor for the detection of episodes of bradycardia and/or hypoxemia among infants.

Detailed description

We will attach an Owlet monitor to infants for a 48-hour period. We will prospectively collect data from this device to determine the accuracy of bradycardia and hypoxemia detection compared with hospital monitors. In addition, we will collect simultaneous high-resolution real time cardiorespiratory data from Philips MP70 patient monitors at the University of Alabama at Birmingham.

Interventions

The Owlet OSS 3.0 is a non-invasive monitoring device. The Sock secures the Sensor to the baby's foot. The Sensor measures the baby's SpO2, heart rate, and movement, and transmits the baby's readings to the Base Station. The Base Station records and monitors the baby's readings and can indicate prompts as needed based on the data sent from the Sensor.

Sponsors

Owlet Baby Care, Inc.
CollaboratorINDUSTRY
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 365 Days

Inclusion criteria

* Off ventilatory support/NCPAP/HFNC and phototherapy for \> 48 hours * Less than one-year corrected age * Current weight \>1500 grams * Parents/legal guardians have provided consent for enrollment

Exclusion criteria

* a major malformation * a neuromuscular condition that affects respiration or causes apnea * active skin breakdown or skin infection * terminal illness or decision to withhold or limit support * We will exclude data from infants who develop shock/sepsis or require ventilatory support or phototherapy during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Bradycardia and/or hypoxemia48 hoursThe diagnostic accuracy of the Owlet OSS 3.0 monitor for detection of bradycardia \<50/min and/or hypoxemia with SpO2 \<80% episodes for ≥3 seconds during a 48-hour period.

Secondary

MeasureTime frameDescription
Diagnostic accuracy48 hoursThe false alarm rate and other key measures of diagnostic accuracy.
Limits of agreement48 hoursThe limits of agreement of overall heart rate and oxygen saturation recordings compared with hospital monitors.
Bradycardia episodes48 hoursThe diagnostic accuracy of the Owlet OSS 3.0 monitor for episodes of bradycardia using alternative definitions of depth and duration (\<50/min; \< 80/min; \< 100/min; lasting ≥ 10 seconds; lasting ≥ 20 seconds).
Hypoxemia episodes48 hoursThe diagnostic accuracy of episodes of intermittent hypoxemia of different severity and duration (\<80%; \<85%; lasting ≥ 10 seconds; lasting ≥ 20 seconds).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026